Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emir Senturk

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
p53 and cell cycle effects after DNA damageEmir Senturk, James J Manfredi
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Determine the effect of p53 on chemosensitivityEmir Senturk, James J Manfredi
Genes & Cancer|November 15, 2012
Mdm2 and tumorigenesis: evolving theories and unsolved mysteriesEmir Senturk, James J Manfredi
Gynecologic Oncology|August 28, 2010
A critical re-appraisal of BRCA1 methylation studies in ovarian cancerEmir Senturk, Samantha Cohen, Peter R Dottino, et al.
Experimental Neurology|November 26, 2003
Human midsized neurofilament subunit induces motor neuron disease in transgenic miceMiguel A Gama Sosa, Victor L Friedrich, Rita DeGasperi, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2009
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumorsYelena Y Janjigian, Wooin Lee, Mark G Kris, et al.
Journal of Ovarian Research|January 24, 2012
IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancerRebecca A Mosig, Mollie Lobl, Emir Senturk, et al.
Genes & Development|September 10, 2013
The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivoPierre-Jacques Hamard, Nicolas Barthelery, Brandon Hogstad, et al.
Journal of Ovarian Research|January 26, 2012
Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancerRebecca A Mosig, Li Lin, Emir Senturk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancerGregory J Riely, Naiyer A Rizvi, Mark G Kris, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
p53 and cell cycle effects after DNA damageEmir Senturk, James J Manfredi
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Determine the effect of p53 on chemosensitivityEmir Senturk, James J Manfredi
Genes & Cancer|November 15, 2012
Mdm2 and tumorigenesis: evolving theories and unsolved mysteriesEmir Senturk, James J Manfredi
Gynecologic Oncology|August 28, 2010
A critical re-appraisal of BRCA1 methylation studies in ovarian cancerEmir Senturk, Samantha Cohen, Peter R Dottino, et al.
Experimental Neurology|November 26, 2003
Human midsized neurofilament subunit induces motor neuron disease in transgenic miceMiguel A Gama Sosa, Victor L Friedrich, Rita DeGasperi, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2009
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumorsYelena Y Janjigian, Wooin Lee, Mark G Kris, et al.
Journal of Ovarian Research|January 24, 2012
IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancerRebecca A Mosig, Mollie Lobl, Emir Senturk, et al.
Genes & Development|September 10, 2013
The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivoPierre-Jacques Hamard, Nicolas Barthelery, Brandon Hogstad, et al.
Journal of Ovarian Research|January 26, 2012
Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancerRebecca A Mosig, Li Lin, Emir Senturk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancerGregory J Riely, Naiyer A Rizvi, Mark G Kris, et al.
Pageof 1